$BMRN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOMARIN PHARMACEUTICAL INC. Get notifications about new insider transactions in BIOMARIN PHARMACEUTICAL INC for free.
Page: < prev 1 ... 29 30 31 32 33 34 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.38 | 900 | 16,543 | 15,995 | 16.9 K to 16 K (-5.33 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.38 | 1,800 | 33,084 | 16,895 | 18.7 K to 16.9 K (-9.63 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.37 | 900 | 16,534 | 18,695 | 19.6 K to 18.7 K (-4.59 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.37 | 100 | 1,837 | 19,595 | 19.7 K to 19.6 K (-0.51 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.35 | 1,800 | 33,032 | 19,695 | 21.5 K to 19.7 K (-8.37 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.35 | 200 | 3,670 | 21,495 | 21.7 K to 21.5 K (-0.92 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.33 | 1,000 | 18,330 | 21,695 | 22.7 K to 21.7 K (-4.41 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.26 | 900 | 16,435 | 22,695 | 23.6 K to 22.7 K (-3.81 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.26 | 700 | 12,782 | 23,595 | 24.3 K to 23.6 K (-2.88 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.25 | 400 | 7,300 | 24,295 | 24.7 K to 24.3 K (-1.62 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.18 | 900 | 16,363 | 24,695 | 25.6 K to 24.7 K (-3.52 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.18 | 100 | 1,818 | 25,595 | 25.7 K to 25.6 K (-0.39 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 6.46 | 10,000 | 64,600 | 25,695 | 15.7 K to 25.7 K (+63.71 %) |
May 23 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.54 | 900 | 16,687 | 15,695 | 16.6 K to 15.7 K (-5.42 %) |
May 23 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.54 | 100 | 1,854 | 16,595 | 16.7 K to 16.6 K (-0.60 %) |
May 23 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.58 | 900 | 16,724 | 16,695 | 17.6 K to 16.7 K (-5.12 %) |
May 23 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.58 | 100 | 1,858 | 17,595 | 17.7 K to 17.6 K (-0.57 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 6.46 | 1,500 | 9,690 | 1,130,000 | |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.86 | 700 | 11,802 | 17,695 | 18.4 K to 17.7 K (-3.81 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.85 | 1,400 | 23,591 | 18,395 | 19.8 K to 18.4 K (-7.07 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.85 | 400 | 6,740 | 19,795 | 20.2 K to 19.8 K (-1.98 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.84 | 500 | 8,421 | 20,195 | 20.7 K to 20.2 K (-2.42 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.83 | 1,500 | 25,245 | 20,695 | 22.2 K to 20.7 K (-6.76 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.82 | 418 | 7,031 | 22,195 | 22.6 K to 22.2 K (-1.85 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.81 | 400 | 6,724 | 22,613 | 23 K to 22.6 K (-1.74 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.81 | 582 | 9,783 | 23,013 | 23.6 K to 23 K (-2.47 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.80 | 600 | 10,081 | 23,595 | 24.2 K to 23.6 K (-2.48 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.80 | 1,000 | 16,800 | 24,195 | 25.2 K to 24.2 K (-3.97 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.78 | 1,400 | 23,493 | 25,195 | 26.6 K to 25.2 K (-5.26 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.78 | 100 | 1,678 | 26,595 | 26.7 K to 26.6 K (-0.37 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.76 | 500 | 8,381 | 26,695 | 27.2 K to 26.7 K (-1.84 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.76 | 1,300 | 21,788 | 27,195 | 28.5 K to 27.2 K (-4.56 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.75 | 700 | 11,726 | 28,495 | 29.2 K to 28.5 K (-2.40 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.75 | 500 | 8,375 | 29,195 | 29.7 K to 29.2 K (-1.68 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.74 | 100 | 1,674 | 29,695 | 29.8 K to 29.7 K (-0.34 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.73 | 1,400 | 23,423 | 29,795 | 31.2 K to 29.8 K (-4.49 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.70 | 1,400 | 23,381 | 31,195 | 32.6 K to 31.2 K (-4.30 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.70 | 100 | 1,670 | 32,595 | 32.7 K to 32.6 K (-0.31 %) |
May 07 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 6.46 | 15,000 | 96,900 | 32,695 | 17.7 K to 32.7 K (+84.77 %) |
May 02 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Buy | P | 6.92 | 2,066 | 14,295 | 4,895 | 2.8 K to 4.9 K (+73.03 %) |
May 02 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 6.92 | 2,553 | 17,664 | 17,695 | 15.1 K to 17.7 K (+16.86 %) |
May 02 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.49 | 500 | 8,246 | 15,142 | 15.6 K to 15.1 K (-3.20 %) |
May 02 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.44 | 500 | 8,221 | 15,642 | 16.1 K to 15.6 K (-3.10 %) |
May 02 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.36 | 500 | 8,180 | 16,142 | 16.6 K to 16.1 K (-3.00 %) |
May 02 2007 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Buy | P | 5.19 | 2,982 | 15,462 | 94,126 | 91.1 K to 94.1 K (+3.27 %) |
May 02 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Buy | P | 5.19 | 2,607 | 13,517 | 2,607 | 0 to 2.6 K |
May 02 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Buy | P | 5.19 | 2,684 | 13,917 | 33,124 | 30.4 K to 33.1 K (+8.82 %) |
Apr 11 2007 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Option Exercise | M | 4.72 | 20,000 | 94,400 | 120,000 | |
Apr 11 2007 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Buy | M | 4.72 | 20,000 | 94,400 | 20,000 | 0 to 20 K |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 6.46 | 5,000 | 32,300 | 1,145,000 | |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.80 | 500 | 8,900 | 16,642 | 17.1 K to 16.6 K (-2.92 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.70 | 400 | 7,080 | 17,142 | 17.5 K to 17.1 K (-2.28 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.70 | 100 | 1,770 | 17,542 | 17.6 K to 17.5 K (-0.57 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.96 | 800 | 14,369 | 17,642 | 18.4 K to 17.6 K (-4.34 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.96 | 200 | 3,592 | 18,442 | 18.6 K to 18.4 K (-1.07 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.95 | 400 | 7,180 | 18,642 | 19 K to 18.6 K (-2.10 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.95 | 100 | 1,795 | 19,042 | 19.1 K to 19 K (-0.52 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.94 | 400 | 7,176 | 19,142 | 19.5 K to 19.1 K (-2.05 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.94 | 100 | 1,794 | 19,542 | 19.6 K to 19.5 K (-0.51 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.91 | 800 | 14,329 | 19,642 | 20.4 K to 19.6 K (-3.91 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.91 | 200 | 3,582 | 20,442 | 20.6 K to 20.4 K (-0.97 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.90 | 400 | 7,160 | 20,642 | 21 K to 20.6 K (-1.90 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.90 | 100 | 1,790 | 21,042 | 21.1 K to 21 K (-0.47 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.89 | 400 | 7,156 | 21,142 | 21.5 K to 21.1 K (-1.86 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.89 | 100 | 1,789 | 21,542 | 21.6 K to 21.5 K (-0.46 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 6.46 | 5,000 | 32,300 | 21,642 | 16.6 K to 21.6 K (+30.04 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.71 | 100 | 1,771 | 16,642 | 16.7 K to 16.6 K (-0.60 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.72 | 400 | 7,088 | 16,742 | 17.1 K to 16.7 K (-2.33 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.83 | 500 | 8,915 | 17,142 | 17.6 K to 17.1 K (-2.83 %) |
Apr 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.85 | 500 | 8,925 | 17,642 | 18.1 K to 17.6 K (-2.76 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Option Exercise | M | 4.00 | 12,500 | 50,000 | 395,233 | |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.41 | 750 | 13,058 | 10,000 | 10.8 K to 10 K (-6.98 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.41 | 500 | 8,705 | 10,750 | 11.3 K to 10.8 K (-4.44 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.40 | 350 | 6,090 | 11,250 | 11.6 K to 11.3 K (-3.02 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.40 | 900 | 15,660 | 11,600 | 12.5 K to 11.6 K (-7.20 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.38 | 800 | 13,904 | 12,500 | 13.3 K to 12.5 K (-6.02 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.37 | 450 | 7,817 | 13,300 | 13.8 K to 13.3 K (-3.27 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.37 | 1,250 | 21,713 | 13,750 | 15 K to 13.8 K (-8.33 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.29 | 1,500 | 25,937 | 15,000 | 16.5 K to 15 K (-9.09 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.29 | 1,000 | 17,290 | 16,500 | 17.5 K to 16.5 K (-5.71 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.26 | 400 | 6,904 | 17,500 | 17.9 K to 17.5 K (-2.23 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.25 | 350 | 6,038 | 17,900 | 18.3 K to 17.9 K (-1.92 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.25 | 500 | 8,625 | 18,250 | 18.8 K to 18.3 K (-2.67 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.24 | 750 | 12,931 | 18,750 | 19.5 K to 18.8 K (-3.85 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.24 | 500 | 8,620 | 19,500 | 20 K to 19.5 K (-2.50 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.23 | 750 | 12,923 | 20,000 | 20.8 K to 20 K (-3.61 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.23 | 500 | 8,615 | 20,750 | 21.3 K to 20.8 K (-2.35 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.18 | 750 | 12,886 | 21,250 | 22 K to 21.3 K (-3.41 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 17.18 | 500 | 8,590 | 22,000 | 22.5 K to 22 K (-2.22 %) |
Apr 04 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Buy | M | 4.00 | 12,500 | 50,000 | 22,500 | 10 K to 22.5 K (+125.00 %) |
Mar 09 2007 | BMRN | BIOMARIN PHARMACEU ... | KLEIN JOSEPH III | Director | Sell | S | 16.39 | 800 | 13,112 | 0 | 800 to 0 (-100.00 %) |
Mar 09 2007 | BMRN | BIOMARIN PHARMACEU ... | KLEIN JOSEPH III | Director | Sell | S | 16.38 | 2,200 | 36,036 | 800 | 3 K to 800 (-73.33 %) |
Mar 09 2007 | BMRN | BIOMARIN PHARMACEU ... | KLEIN JOSEPH III | Director | Sell | S | 16.37 | 900 | 14,733 | 3,000 | 3.9 K to 3 K (-23.08 %) |
Mar 09 2007 | BMRN | BIOMARIN PHARMACEU ... | KLEIN JOSEPH III | Director | Sell | S | 16.36 | 300 | 4,908 | 3,900 | 4.2 K to 3.9 K (-7.14 %) |
Mar 09 2007 | BMRN | BIOMARIN PHARMACEU ... | KLEIN JOSEPH III | Director | Sell | S | 16.36 | 7,800 | 127,608 | 4,200 | 12 K to 4.2 K (-65.00 %) |
Mar 02 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.44 | 700 | 11,508 | 18,142 | 18.8 K to 18.1 K (-3.72 %) |
Mar 02 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.45 | 300 | 4,935 | 18,842 | 19.1 K to 18.8 K (-1.57 %) |
Mar 02 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.56 | 500 | 8,280 | 19,142 | 19.6 K to 19.1 K (-2.55 %) |
Feb 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Option Exercise | M | 6.13 | 13,000 | 79,690 | 195,000 | |
Feb 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Sell | S | 18.37 | 9,816 | 180,320 | 0 | 9.8 K to 0 (-100.00 %) |
Feb 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Sell | S | 18.38 | 900 | 16,542 | 9,816 | 10.7 K to 9.8 K (-8.40 %) |
Feb 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Sell | S | 18.39 | 2,284 | 42,003 | 10,716 | 13 K to 10.7 K (-17.57 %) |
Feb 23 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Buy | M | 6.13 | 13,000 | 79,690 | 13,000 | 0 to 13 K |
Feb 22 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.40 | 1,000 | 18,400 | 19,642 | 20.6 K to 19.6 K (-4.84 %) |
Feb 22 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 16.96 | 13,000 | 220,481 | 20,642 | 33.6 K to 20.6 K (-38.64 %) |
Feb 16 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Option Exercise | M | 7.16 | 15,000 | 107,400 | 280,000 | |
Feb 16 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 20.00 | 15,000 | 300,000 | 2,829 | 17.8 K to 2.8 K (-84.13 %) |
Feb 16 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Buy | M | 7.16 | 15,000 | 107,400 | 17,829 | 2.8 K to 17.8 K (+530.22 %) |
Jan 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Option Exercise | M | 4.00 | 12,500 | 50,000 | 407,733 | |
Jan 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 16.30 | 12,500 | 203,700 | 10,000 | 22.5 K to 10 K (-55.56 %) |
Jan 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Buy | M | 4.00 | 12,500 | 50,000 | 22,500 | 10 K to 22.5 K (+125.00 %) |
Jan 05 2007 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Option Exercise | M | 4.00 | 50,000 | 200,000 | 684,127 | |
Jan 05 2007 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Buy | M | 4.00 | 50,000 | 200,000 | 88,144 | 38.1 K to 88.1 K (+131.08 %) |
Dec 18 2006 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Option Exercise | A | 16.92 | 30,000 | 507,600 | 30,000 | |
Dec 18 2006 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Option Exercise | A | 16.92 | 30,000 | 507,600 | 60,000 | |
Dec 14 2006 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Buy | P | 17.88 | 1,000 | 17,880 | 6,600 | 5.6 K to 6.6 K (+17.86 %) |
Dec 14 2006 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Buy | P | 17.89 | 1,100 | 19,676 | 5,600 | 4.5 K to 5.6 K (+24.44 %) |
Dec 08 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | M | 8.10 | 14,500 | 117,450 | 230,500 | |
Dec 08 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Sell | S | 18.00 | 14,500 | 261,000 | 0 | 14.5 K to 0 (-100.00 %) |
Dec 08 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Buy | M | 8.10 | 14,500 | 117,450 | 14,500 | 0 to 14.5 K |
Nov 30 2006 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Option Exercise | M | 7.16 | 5,000 | 35,800 | 295,000 | |
Nov 30 2006 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 17.23 | 5,000 | 86,150 | 2,829 | 7.8 K to 2.8 K (-63.87 %) |
Nov 30 2006 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Buy | M | 7.16 | 5,000 | 35,800 | 7,829 | 2.8 K to 7.8 K (+176.74 %) |
Nov 22 2006 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Option Exercise | A | 17.54 | 60,000 | 1,052,400 | 208,000 | |
Nov 22 2006 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Option Exercise | A | 17.54 | 80,000 | 1,403,200 | 420,233 | |
Nov 22 2006 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Option Exercise | A | 17.54 | 100,000 | 1,754,000 | 734,127 | |
Nov 22 2006 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Buy | P | 3.43 | 4,368 | 15,000 | 38,144 | 33.8 K to 38.1 K (+12.93 %) |
Nov 22 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | A | 17.54 | 60,000 | 1,052,400 | 245,000 | |
Nov 22 2006 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Option Exercise | A | 17.54 | 90,000 | 1,578,600 | 658,243 | |
Nov 22 2006 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Buy | P | 3.43 | 3,894 | 13,372 | 30,440 | 26.5 K to 30.4 K (+14.67 %) |
Nov 22 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 17.54 | 250,000 | 4,385,000 | 1,150,000 | |
Nov 22 2006 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | P | 6.92 | 2,761 | 19,103 | 33,642 | 30.9 K to 33.6 K (+8.94 %) |
Nov 22 2006 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Option Exercise | A | 17.54 | 100,000 | 1,754,000 | 300,000 | |
Nov 22 2006 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Buy | P | 6.92 | 1,870 | 12,939 | 2,829 | 959 to 2.8 K (+194.99 %) |
Nov 02 2006 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Option Exercise | M | 4.00 | 12,500 | 50,000 | 340,233 | |
Nov 02 2006 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 15.92 | 12,500 | 198,975 | 10,000 | 22.5 K to 10 K (-55.56 %) |
Nov 02 2006 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Buy | M | 4.00 | 12,500 | 50,000 | 22,500 | 10 K to 22.5 K (+125.00 %) |
Aug 31 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | VP, Chief Financial ... | Option Exercise | M | 6.13 | 6,000 | 36,780 | 185,000 | |
Aug 31 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | VP, Chief Financial ... | Option Exercise | M | 8.10 | 20,000 | 162,000 | 191,000 | |
Aug 31 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | VP, Chief Financial ... | Sell | S | 16.00 | 6,000 | 96,000 | 0 | 6 K to 0 (-100.00 %) |
Aug 31 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | VP, Chief Financial ... | Sell | S | 16.00 | 20,000 | 320,000 | 6,000 | 26 K to 6 K (-76.92 %) |
Aug 31 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | VP, Chief Financial ... | Buy | M | 6.13 | 6,000 | 36,780 | 26,000 | 20 K to 26 K (+30.00 %) |
Aug 31 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | VP, Chief Financial ... | Buy | M | 8.10 | 20,000 | 162,000 | 20,000 | 0 to 20 K |
Aug 17 2006 | BMRN | BIOMARIN PHARMACEU ... | KLEIN JOSEPH III | Director | Option Exercise | A | 14.21 | 30,000 | 426,300 | 30,000 | |
Aug 17 2006 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 14.21 | 30,000 | 426,300 | 60,000 | |
Aug 11 2006 | BMRN | BIOMARIN PHARMACEU ... | KLEIN JOSEPH III | Director | Option Exercise | M | 7.72 | 30,000 | 231,600 | 0 | |
Aug 11 2006 | BMRN | BIOMARIN PHARMACEU ... | KLEIN JOSEPH III | Director | Sell | S | 15.52 | 20,000 | 310,320 | 10,000 | 30 K to 10 K (-66.67 %) |
Aug 11 2006 | BMRN | BIOMARIN PHARMACEU ... | KLEIN JOSEPH III | Director | Buy | M | 7.72 | 30,000 | 231,600 | 30,000 | 0 to 30 K |
Aug 08 2006 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Buy | P | 15.35 | 1,000 | 15,350 | 4,500 | 3.5 K to 4.5 K (+28.57 %) |
Aug 02 2006 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Option Exercise | M | 4.00 | 12,500 | 50,000 | 320,072 |